AI-Augmented Automated Endoscope Reprocessing Compliance
#1Medivators (now Cantel Medical, acquired by STERIS in 2022), Olympus, and Getinge are actively integrating sensor arrays, ATP luminescence readers, and machine vision modules into next-generation AER platforms that perform automated post-reprocessing verification — detecting residual protein soil in scope channels, confirming detergent concentration and contact time compliance, and generating blockchain-backed digital audit trails. STERIS's published roadmap and Olympus's Uniport data management platform represent the commercial leading edge of this trend, with FDA 510(k) clearances being sought for AI-assisted reprocessing verification tools. The cognitive core of the scope reprocessing task — the human judgment that a scope is clean enough to use — is being transferred to sensor-verified automated attestation.